Tecan Genomics, Inc.

Morgan Hill, CA

UEI
R4DEKMG6K8N4
CAGE
3VEL5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
18715 Madrone Pkwy Ste A, Morgan Hill, CA 95037, USA
Website
tecan.com
Founded
1980
Employees
1K-5K
Estimated annual revenue
$500M-$1B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$70,155
FY2025 $14,393
FY2024 $0
FY2023 $186,895

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Indiana Department Of Health ELC enhancing detection NU50CK000503 $248,132

Similar vendors

About the company

Tecan Genomics, Inc. is a Switzerland-based manufacturer and distributor of life science laboratory automation and detection solutions, specializing in providing advanced genomic research technologies to federal agencies. The company is registered in SAM.gov as a foreign-owned, for-profit organization that manufactures goods and has been active in federal contracting since 2004. Its primary focus is delivering sophisticated scientific equipment and reagents, with a particular emphasis on RNA sequencing, genomic analysis, and infectious disease research technologies.

Through federal contract awards, Tecan Genomics has consistently provided comprehensive scientific research products to multiple National Institutes of Health (NIH) agencies, including the National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, and National Heart, Lung and Blood Institute. The company's contract portfolio demonstrates expertise in delivering specialized equipment like UltraLow Systems, RNA sequencing kits, targeted genotyping services, and reagents for variant identification. Notable contract awards have included SARS-CoV-2 variant research reagents, universal RNA sequencing kits, methylation analysis systems, and advanced genomic research equipment. All contract awards have been firm fixed-price purchase orders without specific set-aside designations, ranging from approximately $11,000 to $58,453, with performance periods typically spanning several months to a year.

Regarding federal grant awards, Tecan Genomics has limited documented grant activity, with the most recent sub grant award being a February 1, 2024 sub award from the Indiana Department of Health for "ELC ENHANCING DETECTION" programming. This suggests the company's primary federal engagement remains focused on contract-based research support rather than direct grant implementation.

Tecan Genomics holds a significant Blanket Purchase Agreement (BPA) with the Office of Logistics and Acquisition Operations, a single-award indefinite delivery vehicle valued at $100,000,000 through March 31, 2025. This comprehensive BPA covers biological materials procurement, specifically supporting research programs in infectious disease, genomics, and aging across various federal agencies. The BPA enables Tecan Genomics to provide a wide range of products and services, including RNA sequencing kits, methylation analysis, targeted genotyping services, and vacuum separation systems to National Institutes of Health institutes and the Centers for Disease Control and Prevention, facilitating critical scientific research across multiple domains.

Quick answers

Is Tecan Genomics, Inc. registered in SAM.gov?

Yes. Tecan Genomics, Inc.'s SAM.gov registration is active through June 23, 2027.

What is Tecan Genomics, Inc.'s CAGE code?

Tecan Genomics, Inc.'s CAGE code is 3VEL5, and its Unique Entity ID (UEI) is R4DEKMG6K8N4.

How much has Tecan Genomics, Inc. received in federal contracts?

Federal contracts obligated $14,393 to Tecan Genomics, Inc. in fiscal year 2025 and $131,132 in fiscal years 2023 through 2027.

What is Tecan Genomics, Inc.'s most recent federal award?

Tecan Genomics, Inc.'s most recent federal contract award is This purchase is to obtain a 3 month supply of reagents for a project to identify sars-COV2 variants in patient samples… (75N92E25P00012), from National Human Genome Research Institute (NIH), on October 18, 2024.

On GovTribe

See Tecan Genomics, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe